The Value of Diagnostic Information in Heart Failure
A case study, conducted by MedTech Europe in collaboration with Executive Insight, explores how the use of information generated by In-Vitro Diagnostics, such as cardiac biomarkers, can address current shortcomings in Heart Failure care (e.g. missed or late diagnosis and ineffective monitoring). The case also calls on policymakers across Europe to better leverage this value and hence design policies that can contribute to improve outcomes for Heart Failure patients.
We co-developed this case study together with MedTech Europe. You can find the entire publication on the subject here: https://www.medtecheurope.org/access-to-medical-technology/value-of-diagnostic-information-vodi/
You can download a pdf of the 2-pager summarizing the case study here.